Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
10.19
-0.35 (-3.32%)
At close: Oct 23, 2026, 4:00 PM EDT
10.19
0.00 (0.00%)
After-hours: Oct 23, 2026, 4:37 PM EDT
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $585.28 million as of October 23, 2026. It is the 13,112th most valuable company in the world and the 2,604th biggest in the United States. Its market cap has increased by 319.27% in one year.
Market Cap
585.28M
Enterprise Value
347.37M
1-Year Change
319.27%
Global Rank
Country Rank
#2,604 United States
Category
ChartMarket Cap Chart
Since August 10, 2021, Climb Bio's market cap has increased from $403.20M to $585.28M, an increase of 45.16%. That is a compound annual growth rate of 7.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 585.28M | 206.46% |
| Dec 31, 2025 | 190.98M | 57.83% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
| Aug 10, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 663.98M |
| Avalo Therapeutics | 662.87M |
| Candel Therapeutics | 661.12M |
| Gyre Therapeutics | 654.23M |
| Attovia Therapeutics | 640.94M |
| Olema Pharmaceuticals | 634.36M |
| Zevra Therapeutics | 621.75M |
| MiMedx Group | 615.11M |